Registration process for modified new drugs to be simplified

Published: 2003-04-01 07:00:00

Updated: 2003-04-01 07:00:00

The KFDA plans to simplify the registration process for a modified new drug in order to enhance the industrial competitiveness and to encourage the development of such modified new drugs, which include a new drug modified only with its salt, dosage form, composition and efficacy. The regulations ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK